About Elastrin
Elastrin is a company based in Simpsonville (United States) founded in 2017.. Elastrin has raised $17.25 million across 7 funding rounds from investors including LIfT Biosciences, HHS and SCRA. Elastrin offers products and services including Cardiovascular Therapies. Elastrin operates in a competitive market with competitors including Moderna, Sana Biotechnology, Semma Therapeutics, Adocia and Rezolute, among others.
- Headquarter Simpsonville, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Elastrin Therapeutics Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$17.25 M (USD)
in 7 rounds
-
Latest Funding Round
$500 K (USD), Series A
Sep 11, 2024
-
Investors
LIfT Biosciences
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Elastrin
Elastrin offers a comprehensive portfolio of products and services, including Cardiovascular Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops treatments targeting root causes of cardiovascular diseases through research
Unlock access to complete
Unlock access to complete
Advisor Team
7 people
Co Team
2 people
Board Team
1 people
CSO Team
1 people
Operational Team
1 people
Research Team
1 people
Unlock access to complete
Funding Insights of Elastrin
Elastrin has successfully raised a total of $17.25M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $500 thousand completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series A — $500,000
-
First Round
First Round
(16 Nov 2018)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series A - Elastrin | Valuation |
investors |
|
| Oct, 2023 | Amount | Series A - Elastrin | Valuation |
investors |
|
| Aug, 2023 | Amount | Series A - Elastrin | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Elastrin
Elastrin has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include LIfT Biosciences, HHS and SCRA. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage German tech and biotech investments are conducted.
|
Founded Year | Domain | Location | |
|
Startups are accelerated across sectors by SCRA.
|
Founded Year | Domain | Location | |
|
Neutrophil-based cell therapies for solid tumors are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Elastrin
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Elastrin
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Elastrin Comparisons
Competitors of Elastrin
Elastrin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Sana Biotechnology, Semma Therapeutics, Adocia and Rezolute, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Elastrin
Frequently Asked Questions about Elastrin
When was Elastrin founded?
Elastrin was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Elastrin located?
Elastrin is headquartered in Simpsonville, United States. It is registered at Simpsonville, South Carolina, United States.
Is Elastrin a funded company?
Elastrin is a funded company, having raised a total of $17.25M across 7 funding rounds to date. The company's 1st funding round was a Series A of $2M, raised on Nov 16, 2018.
What does Elastrin do?
Elastrin was founded in 2017 in Simpsonville, United States, within the biotechnology sector focused on cardiovascular and respiratory therapeutics. A proprietary platform is utilized to identify and restore degraded elastin in arteries and lungs by eliminating harmful calcification that contributes to vessel thickening. Drug targets are managed through this approach, supporting treatments for related diseases. Operations center on research and development of these therapeutic solutions.
Who are the top competitors of Elastrin?
Elastrin's top competitors include Moderna, Sana Biotechnology and Semma Therapeutics.
What products or services does Elastrin offer?
Elastrin offers Cardiovascular Therapies.
Who are Elastrin's investors?
Elastrin has 4 investors. Key investors include LIfT Biosciences, HHS, SCRA, and Kizoo.